Treatment of Lung Cancer by Peptide-Modified Liposomal Irinotecan Endowed with Tumor Penetration and NF-κB Inhibitory Activities

Yang Hu(Stanford University), Weiyue Lu(University of Shanghai for Science and Technology), Kuan Jiang(Sun Yat-sen University), Yao-Zhong Lin(Vanderbilt University), Shengyu Yao(Fudan University), Gang Wei(Fudan University), Huan Wang(Henan Agricultural University), Yu Liu(Peking University), Xiaoyi Wang(University of Electronic Science and Technology of China), Yanyu Zhang(Peking University)
Molecular Pharmaceutics
August 20, 2020
Cited by 19


Related Papers